100 Percent Fed Up By Danielle
The U.S. Food and Drug Administration (FDA) approved the Biologics License Application for the Nuvaxovid (Novavax) COVID-19 jab in adults 65 years and older and individuals 12 through 64 with at least one underlying condition.
“Today’s approval solidifies a pathway for Americans aged 65 and older and those aged 12 through 64 with an underlying condition that puts them at high risk for severe outcomes from COVID-19 to have access to a protein-based, non-mRNA COVID-19 vaccine,” said John C. Jacobs, President and Chief Executive Officer, Novavax.
“Market research and U.S. CDC statistics indicate that older individuals and those with underlying conditions are the populations most likely to seek out COVID-19 vaccination seasonally. This significant milestone demonstrates our commitment to these populations and is a significant step towards availability of our protein-based vaccine option,” Jacobs added…
READ FULL ARTICLE HERE… (100percentfedup.com)
Home | Caravan to Midnight (zutalk.com)
